Table 2.
Laboratory results of the patients admitted in Kenyan health facilities with COVID-19
| Parameter | All patients | Survivors | Non-survivors | P value |
| Leucocyte count (×109 L; normal range 4–10) | n=448 | n=352 | n=96 | |
| Increased | 99 (22%) | 55 (16%) | 44 (46%) | <0.001 |
| Segmented neutrophils (normal range 45%–75%) | n=354 | n=94 | ||
| Decreased | 289 (65%) | 223 (63%) | 66 (70%) | <0.001 |
| Increased | 41 (11%) | 23 (6%) | 18 (19%) | 0.468 |
| Lymphocyte (normal range 25%–40%) | n=355 | n=93 | ||
| Decreased | 309 (69%) | 227 (64%) | 82 (88%) | <0.001 |
| Increased | 60 (13%) | 58 (16%) | 2 (2%) | <0.001 |
| Haemoglobin (g/dL normal range: male 14–17, female 12–16) | n=448 | n=349 | n=99 | |
| Decreased | 128 (29%) | 76 (22%) | 52 (53%) | <0.001 |
| Aminotransferase, alanine (U/L normal range:<35) | n=421 | n=316 | n=105 | |
| Increased | 201 (48%) | 132 (42%) | 69 (66%) | <0.001 |
| Aminotransferase, aspartate (U/L normal range:<35) | n=421 | n=316 | n=105 | |
| Increased | 214 (51%) | 131 (41%) | 83 (79%) | <0.001 |
| Lactose dehydrogenase (U/L normal range: 60–100) | n=104 | n=66 | n=38 | |
| Increased | 101 (97%) | 64 (97%) | 37 (97%) | 1 |
| Potassium (mmol/L normal range: 3.5–5) | n=433 | n=328 | n=105 | |
| Decreased | 35 (8%) | 28 (9%) | 7 (7%) | 0.030 |
| Increased | 61 (15%) | 38 (12%) | 23 (22%) | 0.178 |
| C reactive protein (mg/L normal range:<5) | n=197 | n=137 | n=60 | |
| Increased | 155 (79%) | 96 (70%) | 59 (98%) | <0.001 |